<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="plosl" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">plosl</book-part-id>
      <title-group>
        <title>Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL)</title>
        <alt-title alt-title-type="alt-title">Synonym: Nasu-Hakola Disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Paloneva</surname>
            <given-names>Juha</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Surgery<break/>Central Finland Hospital<break/>Jyvaskyla, Finland</aff>
          <email>juha.paloneva@fimnet.fi</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Autti</surname>
            <given-names>Taina</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>University of Helsinki<break/>Helsinki Medical Imaging Center<break/>Helsinki, Finland</aff>
          <email>autttaina.autti@hus.fi</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hakola</surname>
            <given-names>Panu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Forensic Medicine <break/>Niuvanniemi Hospital <break/>University of Kuopio<break/>Kuopio, Finland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Haltia</surname>
            <given-names>Matti J</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Pathology <break/>Haartman Institute <break/>University of Helsinki<break/>Helsinki, Finland</aff>
          <email>matti.j.haltia@helsinki.fi</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>24</day>
          <month>1</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>12</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>16</day>
          <month>4</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pkd-ar" document-type="chapter">Polycystic Kidney Disease, Autosomal Recessive</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="poly" document-type="chapter">Polymicrogyria Overview</related-object>
      <abstract id="plosl.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is characterized by fractures (resulting from radiologically demonstrable polycystic osseous lesions), frontal lobe syndrome, and progressive presenile dementia beginning in the fourth decade. The clinical course of PLOSL can be divided into four stages: (1) The latent stage is characterized by normal early development. (2) The osseous stage (3rd decade of life) is characterized by pain and tenderness, mostly in ankles and feet, usually following strain or injury. Fractures are typically diagnosed several years later, most commonly in the bones of the extremities. (3) In the early neurologic stage (4th decade of life), a change of personality begins to develop insidiously. Affected individuals show a frontal lobe syndrome (loss of judgment, euphoria, loss of social inhibitions, disturbance of concentration, and lack of insight, libido, and motor persistence) leading to serious social problems. (4) The late neurologic stage is characterized by progressive dementia and loss of mobility. Death usually occurs before age 50 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The combination of radiologically demonstrable polycystic osseous lesions, frontal lobe syndrome, and progressive presenile dementia beginning in the fourth decade is diagnostic. Fractures of the wrists or ankles after minor trauma with typical polycystic osseous lesions identified on x-ray examination suggest the possibility of PLOSL. In uncertain cases, molecular genetic testing helps to establish the diagnosis. <italic toggle="yes">TYROBP</italic> (<italic toggle="yes">DAP12</italic>) and <italic toggle="yes">TREM2</italic> are the only two genes in which pathogenic variants are known to cause PLOSL.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment is symptomatic. Orthopedic surgery and/or devices may be of value in individual cases. Antiepileptic drugs can be used to prevent epileptic seizures and secondary worsening of the condition.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Some of the social consequences of PLOSL may be avoided if family members are informed early about the nature of the disorder.</p>
          <p><italic toggle="yes">Surveillance</italic>: Intervals for follow up of bone lesions and neurologic and psychiatric manifestations must be determined individually.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>PLOSL is inherited in an autosomal recessive manner. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="plosl.Diagnosis">
        <title>Diagnosis</title>
        <sec id="plosl.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) should be suspected in individuals with the combination of the following features:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Radiologically demonstrable polycystic osseous lesions</bold> and fractures of the wrists and ankles after minor trauma at the mean age of 27 years (range 18-33 years) [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. Cyst-like lesions and loss of bone trabeculae are most conspicuous in the fingers and in the carpal and tarsal bones (see <xref ref-type="fig" rid="plosl.F1">Figure 1</xref> and <xref ref-type="fig" rid="plosl.F2">Figure 2</xref>) [<xref ref-type="bibr" rid="plosl.REF.m_kel_.1982.51">M&#x000e4;kel&#x000e4; et al 1982</xref>, <xref ref-type="bibr" rid="plosl.REF.nwawka.2014.1449">Nwawka et al 2014</xref>]. See also <xref ref-type="fig" rid="plosl.F2">Figures 2</xref> and <xref ref-type="fig" rid="plosl.F3">3</xref> in <xref ref-type="bibr" rid="plosl.REF.nwawka.2014.1449">Nwawka et al [2014]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://link.springer.com/article/10.1007/s00256-014-1887-5/fulltext.html">full text</ext-link>). If an individual has multiple lytic or cyst-like lesions on radiograph primarily in the distal extremities, CT and MRI are useful in making an accurate diagnosis [<xref ref-type="bibr" rid="plosl.REF.nwawka.2014.1449">Nwawka et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Frontal lobe syndrome</bold> in the fourth decade manifested by euphoria and loss of judgment and social inhibitions</p>
            </list-item>
            <list-item>
              <p><bold>Progressive presenile dementia</bold> beginning in the fourth decade. Dementia is mild at the onset of neurologic symptoms. The disease culminates in severe dementia; affected individuals typically die before age 50 years.</p>
            </list-item>
          </list>
        </sec>
        <sec id="plosl.Testing">
          <title>Testing</title>
          <p><bold>Bone biopsy</bold> is not required to establish the diagnosis. The cyst-like bone lesions are filled with lipid material that microscopically consists of characteristic 1-2 &#x000b5;m-thick lipid membranes and amorphous lipid substance.</p>
          <p><bold>Neuroradiologic examination</bold> (<xref ref-type="fig" rid="plosl.F3">Figure 3</xref>, <xref ref-type="fig" rid="plosl.F4">Figure 4</xref>, <xref ref-type="fig" rid="plosl.F5">Figure 5</xref>)</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cerebral atrophy</bold> (dilated ventricles in addition with the atrophy of the basal ganglia and thalamus, prominent sulci or thin corpus callosum) of varying degree is a constant finding on CT and MRI and is evident even before the appearance of neuropsychiatric symptoms. In addition to progressive cerebral atrophy, cerebellar atrophy may appear [<xref ref-type="bibr" rid="plosl.REF.araki.1991.793">Araki et al 1991</xref>, <xref ref-type="bibr" rid="plosl.REF.hakola.1993.370">Hakola &#x00026; Puranen 1993</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>, <xref ref-type="bibr" rid="plosl.REF.solje.2014.1780.e13">Solje et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Bilateral calcifications of the basal ganglia</bold> are a common finding on CT. Most often, they are situated in the putamina. Calcifications, atrophy of the basal ganglia, and progressively increasing and abnormally high bicaudate ratios may occur before CNS symptoms [<xref ref-type="bibr" rid="plosl.REF.bird.1983.81">Bird et al 1983</xref>, <xref ref-type="bibr" rid="plosl.REF.araki.1991.793">Araki et al 1991</xref>, <xref ref-type="bibr" rid="plosl.REF.hakola.1993.370">Hakola &#x00026; Puranen 1993</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. The basal ganglia and thalamus, particularly the putamina, may show very low signal intensities on T<sub>2</sub>-weighted MR images [<xref ref-type="bibr" rid="plosl.REF.araki.1991.793">Araki et al 1991</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Increased signal intensities of the cerebral white matter</bold> are usually found on T<sub>2</sub>-weighted images after the appearance of clinical CNS symptoms. These white matter changes are diffuse and have no region of predilection, apart from the frontal lobes. The changes are usually centrally located (periventricular white matter, centrum semiovale, internal capsules). As the disease progresses, the high periventricular signal intensity spreads toward the periphery sparing most of the arcuate fibers. In some instances, the white matter changes also extend to the cortex. However, the white matter may look normal in some individuals with CNS symptoms [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>SPECT and PET findings</bold> are variable. Hypoperfusion of the cortical areas, thalamus, and basal ganglia have been reported [<xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>, <xref ref-type="bibr" rid="plosl.REF.takeshita.2005.309">Takeshita et al 2005</xref>].</p>
            </list-item>
          </list>
          <p><bold>Electroencephalogram</bold> is normal early in the disease. With advancing disease, individuals show accentuation of theta and delta activity. Initially, theta is typically rhythmic, 6-8 Hz, dominating in the centrotemporal areas; later, diffuse slowing becomes evident. In the late stage of the disease, irritative activity usually appears on EEG [<xref ref-type="bibr" rid="plosl.REF.bird.1983.81">Bird et al 1983</xref>, <xref ref-type="bibr" rid="plosl.REF.hakola.1983.515">Hakola &#x00026; Partanen 1983</xref>, <xref ref-type="bibr" rid="plosl.REF.motohashi.1995.549">Motohashi et al 1995</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>].</p>
        </sec>
        <sec id="plosl.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of PLOSL is established in a proband with identification of biallelic pathogenic variants in either <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> (see <xref ref-type="table" rid="plosl.T.summary_of_molecular_genetic_tes">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serial single-gene</bold>
<bold>testing.</bold> The order of testing is based on the individual&#x02019;s ethnicity. In individuals outside of Finland and Japan, pathogenic variants in <italic toggle="yes">TREM2</italic> appear to be more frequent than in <italic toggle="yes">TYROBP</italic> [<xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sequence analysis of each gene is performed first.</p>
                </list-item>
                <list-item>
                  <p>If only one or no pathogenic variant is found, deletion/duplication analysis is performed next.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>A</bold>
<bold>multi-gene panel</bold> that includes <italic toggle="yes">TREM2</italic> and <italic toggle="yes">TYROBP</italic> and other genes of interest (see <xref ref-type="sec" rid="plosl.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes the genes in listed in <xref ref-type="table" rid="plosl.T.summary_of_molecular_genetic_tes">Table 1</xref>) fails to confirm a diagnosis in an individual with features of PLOSL. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="plosl.T.summary_of_molecular_genetic_tes" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of PLOSL Attributed to Mutation of This Gene</th>
                  <th id="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TREM2</italic>
                  </td>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2,&#x000a0;3,&#x000a0;4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TYROBP</italic>
                  </td>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown</td>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2,&#x000a0;6,&#x000a0;7,&#x000a0;8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_plosl.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5,&#x000a0;8,&#x000a0;9</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="plosl.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="plosl" object-id="plosl.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="plosl.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="plosl.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="plosl.TF.1.3">
                <label>3. </label>
                <p>Pathogenic variants reported in more than one family are <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Trp78Ter</xref> (found in 2 Swedish families) and <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Val126Gly</xref> (found in one Canadian family and one British family, both originating from Sri Lanka).</p>
              </fn>
              <fn id="plosl.TF.1.4">
                <label>4. </label>
                <p>Most affected individuals tested to date are homozygous for their pathogenic variant [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
              </fn>
              <fn id="plosl.TF.1.5">
                <label>5. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="plosl.TF.1.6">
                <label>6. </label>
                <p>Most affected individuals tested to date are homozygous for their pathogenic variant [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
              </fn>
              <fn id="plosl.TF.1.7">
                <label>7. </label>
                <p>Pathogenic variants reported in more than one family: <xref ref-type="table" rid="plosl.T.selected_tyrobp_pathogenic_varia">p.Met48TrpfsTer6</xref> (found in an unknown portion of affected individuals of Japanese ethnicity); <xref ref-type="table" rid="plosl.T.selected_tyrobp_pathogenic_varia">p.Met1Thr</xref> (found in 2 Japanese families) [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>]</p>
              </fn>
              <fn id="plosl.TF.1.8">
                <label>8. </label>
                <p>Variant detection frequency is 100% of affected individuals from Finland, unknown percentage of affected individuals from Sweden and Norway [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
              </fn>
              <fn id="plosl.TF.1.9">
                <label>9. </label>
                <p>All Finnish individuals with PLOSL are homozygous for deletion of exons 1-4 (c.-2897_276+1334del)<italic toggle="yes">.</italic> Deletions of exons 1-4 have also been found in affected individuals in other countries as well [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="plosl.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="plosl.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical course of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) can be divided into four stages: latent, osseous, early neurologic, and late neurologic [<xref ref-type="bibr" rid="plosl.REF.hakola.1972.1">Hakola 1972</xref>, <xref ref-type="bibr" rid="plosl.REF.hakola.a">Hakola 1990a</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
          <p><bold>Latent stage.</bold> Early development is normal.</p>
          <p><bold>Osseous stage (3rd decade of life).</bold> The first symptoms of PLOSL appear in early adulthood as pain and tenderness, mostly in the ankles and feet, usually following strain or a minor accident. Fractures are typically diagnosed several years later, most commonly in the bones of the extremities [<xref ref-type="bibr" rid="plosl.REF.m_kel_.1982.51">M&#x000e4;kel&#x000e4; et al 1982</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. The first fractures usually occur shortly before age 30 years; however, affected individuals may have been experiencing pain and swelling of the ankles and wrists after strain for years. The fractures heal well. It is important to note that some individuals may present with neurologic symptoms without any preceding osseous manifestations [<xref ref-type="bibr" rid="plosl.REF.matsuo.1982.123">Matsuo et al 1982</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>, <xref ref-type="bibr" rid="plosl.REF.chouery.2008.e194">Chouery et al 2008</xref>, <xref ref-type="bibr" rid="plosl.REF.bock.2013.115">Bock et al 2013</xref>].</p>
          <p><bold>Early neurologic stage (4th decade of life).</bold> Personality changes begin insidiously in the fourth decade. Affected individuals show progressive loss of judgment, leading to serious social consequences, including divorce, unemployment, and financial trouble [<xref ref-type="bibr" rid="plosl.REF.hakola.1990b.21">Hakola 1990b</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>, <xref ref-type="bibr" rid="plosl.REF.ilonen.2012.236">Ilonen et al 2012</xref>]. Some individuals may attempt suicide. The full-blown picture of frontal lobe syndrome subsequently appears: loss of judgment; euphoria; lack of social inhibitions, including <italic toggle="yes">Witzelsucht</italic>; disturbance of concentration; and lack of insight, libido, and motor persistence.</p>
          <p>Progressive signs of upper motor neuron involvement (spasticity, extensor plantar reflexes) are noticed. With advancing disease, lack of initiative and activity conceal the aforementioned symptoms [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>].</p>
          <p>Memory disturbances begin at approximately the same age as the personality changes, and are best detectable by psychometric tests [<xref ref-type="bibr" rid="plosl.REF.hakola.1998.39">Hakola 1998</xref>, <xref ref-type="bibr" rid="plosl.REF.vanhanen.2013.10">Vanhanen et al 2013</xref>]. The memory disturbance is less severe than the personality change, and affected individuals retain basic personal information until the last stage of the disease.</p>
          <p>Other disturbances of higher cortical function, such as motor aphasia, agraphia, acalculia, and apraxia, appear only at the last stage of the disease.</p>
          <p>Affected individuals may develop postural dyspraxia: they walk or sit in peculiar skewed postures. Involuntary athetotic or choreatic movements or myoclonic twitches are common. Individuals who reach their mid-thirties frequently experience epileptic seizures. In some individuals, impotence or lack of libido and urinary incontinence are among the first symptoms [<xref ref-type="bibr" rid="plosl.REF.hakola.1972.1">Hakola 1972</xref>, <xref ref-type="bibr" rid="plosl.REF.minagawa.1985.38">Minagawa et al 1985</xref>, <xref ref-type="bibr" rid="plosl.REF.ishigooka.1993.179">Ishigooka et al 1993</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>].</p>
          <p><bold>Late neurologic stage.</bold> In the last stage of the disease, individuals lose their ability to walk and progress to a vegetative state. Primitive reflexes, such as visual and tactile grasp and mouth-opening reflexes, as well as the sucking reflex, may become noticeable. Affected individuals typically die before age 50 years [<xref ref-type="bibr" rid="plosl.REF.verloes.1997.753">Verloes et al 1997</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>].</p>
          <p><bold>Bone pathology.</bold> The cyst-like bone lesions are filled with lipid material that microscopically consists of characteristic 1-2 &#x000b5;m-thick lipid membranes and amorphous lipid substance [<xref ref-type="bibr" rid="plosl.REF.nasu.1973.539">Nasu et al 1973</xref>, <xref ref-type="bibr" rid="plosl.REF.akai.1977.802">Akai et al 1977</xref>, <xref ref-type="bibr" rid="plosl.REF.kitajima.1989.35">Kitajima et al 1989</xref>]. See <xref ref-type="fig" rid="plosl.F6">Figure 6</xref>.</p>
          <p><bold>Neuropathology.</bold> Generalized cerebral gyral atrophy with frontal accentuation is observed at autopsy. The corpus callosum is abnormally thin. The central white matter is severely reduced in amount, greyish, and tough. The basal ganglia, particularly the caudate nuclei, are variably reduced in size [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. All affected individuals show marked <italic toggle="yes">hydrocephalus e vacuo</italic>.</p>
          <p>Histologic examination reveals scattered neurons showing features of central chromatolysis. Intraneuronal or glial pathologic inclusions have not been observed [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. Neuronal loss as well as astrocytic proliferation and hypertrophy are observed in the caudate nuclei. In addition, scattered calcospherites are seen, particularly in the putamina and globi pallidi [<xref ref-type="bibr" rid="plosl.REF.amano.1987.294">Amano et al 1987</xref>, <xref ref-type="bibr" rid="plosl.REF.miyazu.1991.414">Miyazu et al 1991</xref>, <xref ref-type="bibr" rid="plosl.REF.kalimo.1994.353">Kalimo et al 1994</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. Thalamic degeneration may occur [<xref ref-type="bibr" rid="plosl.REF.tanaka.1980.193">Tanaka 1980</xref>, <xref ref-type="bibr" rid="plosl.REF.amano.1987.294">Amano et al 1987</xref>, <xref ref-type="bibr" rid="plosl.REF.miyazu.1991.414">Miyazu et al 1991</xref>, <xref ref-type="bibr" rid="plosl.REF.kobayashi.2000.98">Kobayashi et al 2000</xref>]. Affected individuals show advanced loss of axons and myelin and a pronounced astrocytic reaction in the centrum semiovale, accentuated in the frontal and temporal lobes, with moderate involvement of the gyral white matter. In addition, widespread activation of microglia in the cerebral white matter is seen [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. Scattered small arterioles and capillaries in the deep frontal and temporal white matter show concentric thickening of the vascular wall with multiple thickened basement membranes and narrowing or obliteration of the lumen [<xref ref-type="bibr" rid="plosl.REF.kalimo.1994.353">Kalimo et al 1994</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>]. The cerebral cortices are less severely affected [<xref ref-type="bibr" rid="plosl.REF.aoki.2011.135">Aoki et al 2011</xref>].</p>
          <p><bold>Pathologic findings in other organs.</bold> Characteristic lipomembranous changes have been described in systemic adipose tissue [<xref ref-type="bibr" rid="plosl.REF.nasu.1973.539">Nasu et al 1973</xref>]. Pathologic manifestations in organs other than the CNS and the skeletal system have been insufficiently characterized.</p>
        </sec>
        <sec id="plosl.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Individuals with homozygous pathogenic variants in <italic toggle="yes">TYROBP</italic> or <italic toggle="yes">TREM2</italic> develop similar CNS manifestations [<xref ref-type="bibr" rid="plosl.REF.paloneva.2002.656">Paloneva et al 2002</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
          <p>However, osseous pathology is not always present or diagnosed.</p>
          <list list-type="bullet">
            <list-item>
              <p>A biallelic deletion <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">c.40+3delAGG</xref> in the 5&#x02019; consensus donor splice site in intron 1 of <italic toggle="yes">TREM2</italic> has been reported to cause a dementia syndrome resembling PLOSL without evident osseous manifestations [<xref ref-type="bibr" rid="plosl.REF.chouery.2008.e194">Chouery et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>In addition, some homozygous pathogenic variants in <italic toggle="yes">TREM2</italic> (<xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Gln33Ter</xref>, <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Thr66Met</xref>, and <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Tyr38Cys</xref>) have been reported to present as a frontotemporal dementia-like syndrome with CNS manifestations typical of PLOSL but without bone involvement [<xref ref-type="bibr" rid="plosl.REF.guerreiro.2013c.78">Guerreiro et al 2013c</xref>].</p>
            </list-item>
            <list-item>
              <p>The homozygous <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Gln33Ter</xref> pathogenic variant has also been reported in a patient with PLOSL. This patient presented with the typical radiologic bone pathology but fractures were not diagnosed [<xref ref-type="bibr" rid="plosl.REF.bock.2013.115">Bock et al 2013</xref>]. The homozygous <xref ref-type="table" rid="plosl.T.selected_trem2_pathogenic_varian">p.Thr66Met</xref> pathogenic variant was reported in a family with CNS manifestations typical of PLOSL but without diagnosed osseous manifestations [<xref ref-type="bibr" rid="plosl.REF.le_ber.2014.2419.e23">Le Ber et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="plosl.Nomenclature">
          <title>Nomenclature</title>
          <p>PLOSL or Nasu-Hakola disease is the recommended name.</p>
          <p>Some authors have preferred the abbreviation "PLO-SL."</p>
          <p>The first affected individuals were described in the 1960s independently by J&#x000e4;rvi and Hakola in Finland and Nasu in Japan.</p>
          <p>In the early literature, PLOSL was also known as &#x0201c;membranous lipodystrophy.&#x0201d; This term is outdated and should not be used.</p>
        </sec>
        <sec id="plosl.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of PLOSL is highest in Finland, where it is estimated at 1:1,000,000 to 2:1,000,000 [<xref ref-type="bibr" rid="plosl.REF.pekkarinen.1998.362">Pekkarinen et al 1998</xref>]. The prevalence of PLOSL in other countries is lower; no detailed data on the prevalence elsewhere are available. Most affected individuals have been diagnosed in Japan (&#x0003e;100 cases) [<xref ref-type="bibr" rid="plosl.REF.pekkarinen.1998.362">Pekkarinen et al 1998</xref>]. Single families with PLOSL have been diagnosed worldwide [<xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
        </sec>
      </sec>
      <sec id="plosl.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No disorders other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be caused by mutation of <italic toggle="yes">TYROBP</italic>.</p>
        <p>Some pathogenic variants in <italic toggle="yes">TREM2</italic> have been reported to present as a frontotemporal dementia-like syndrome with CNS manifestations typical of PLOSL but without clinical bone involvement (see <xref ref-type="sec" rid="plosl.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> and <xref ref-type="sec" rid="plosl.Differential_Diagnosis">Differential Diagnosis</xref>) [<xref ref-type="bibr" rid="plosl.REF.chouery.2008.e194">Chouery et al 2008</xref>, <xref ref-type="bibr" rid="plosl.REF.guerreiro.2013c.78">Guerreiro et al 2013c</xref>, <xref ref-type="bibr" rid="plosl.REF.le_ber.2014.2419.e23">Le Ber et al 2014</xref>]. It is unclear if the disease caused by these pathogenic variants is a variant of PLOSL or a distinct form of dementia.</p>
        <p>Heterozygous rare variants in <italic toggle="yes">TREM2</italic> are associated with an increase in the risk of <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer disease</related-object> [<xref ref-type="bibr" rid="plosl.REF.guerreiro.2013b.117">Guerreiro et al 2013b</xref>, <xref ref-type="bibr" rid="plosl.REF.jonsson.2013.107">Jonsson et al 2013</xref>, <xref ref-type="bibr" rid="plosl.REF.jin.2014.5838">Jin et al 2014</xref>].</p>
      </sec>
      <sec id="plosl.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The combination of frontal-type dementia beginning in the fourth decade and radiologically demonstrable polycystic osseous lesions makes it easy to clinically distinguish PLOSL from the established forms of familial and non-familial frontotemporal dementia (e.g., Pick's disease, nonspecific frontal lobe degeneration, and the various entities of <related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter">frontotemporal dementia and parkinsonism linked to chromosome 17</related-object>), in several of which pathogenic variants in <italic toggle="yes">MAPT,</italic> encoding the protein tau, have been reported.</p>
        <p>It should be noted that some pathogenic variants in <italic toggle="yes">TREM2</italic> have been reported to cause dementia and frontal lobe syndrome typical of PLOSL without osseous manifestations [<xref ref-type="bibr" rid="plosl.REF.chouery.2008.e194">Chouery et al 2008</xref>, <xref ref-type="bibr" rid="plosl.REF.bock.2013.115">Bock et al 2013</xref>, <xref ref-type="bibr" rid="plosl.REF.guerreiro.2013a.2890.e1">Guerreiro et al 2013a</xref>, <xref ref-type="bibr" rid="plosl.REF.guerreiro.2013c.78">Guerreiro et al 2013c</xref>, <xref ref-type="bibr" rid="plosl.REF.le_ber.2014.2419.e23">Le Ber et al 2014</xref>]. Therefore, PLOSL should be considered in all cases of early-onset dementia of unknown origin.</p>
      </sec>
      <sec id="plosl.Management">
        <title>Management</title>
        <sec id="plosl.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with PLOSL, the following evaluations are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Radiographs of the bones of wrists, hands, ankles, and feet to determine the extent of osseous manifestations of the disease</p>
            </list-item>
            <list-item>
              <p>Brain CT and/or MRI to determine the extent of CNS manifestations</p>
            </list-item>
            <list-item>
              <p>Neurologic and neuropsychological examination to establish the extent of neurologic impairment and cognitive disturbance</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="plosl.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Only symptomatic treatment is available.</p>
          <p>Relief of pain after curettage and iliac bone grafting of painful lesions in the talus has been reported [<xref ref-type="bibr" rid="plosl.REF.ar_kan.2014">Ar&#x00131;kan et al 2014</xref>]. Supportive orthopedic devices may be of value in individual cases. The fractures have been reported to heal well [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>].</p>
          <p>Epileptic seizures may worsen the individual's condition. Consequently, adequate antiepileptic drugs (AEDs) are important.</p>
        </sec>
        <sec id="plosl.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>No therapy to delay or halt the progression of the disease is known.</p>
        </sec>
        <sec id="plosl.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Social problems (unemployment, divorce, financial troubles, and alcoholism) and suicidal tendency are often associated with the progression of the disease [<xref ref-type="bibr" rid="plosl.REF.ilonen.2012.236">Ilonen et al 2012</xref>]. Some of the social consequences may be avoided if family members are informed early about the nature of the disorder [<xref ref-type="bibr" rid="plosl.REF.hakola.1990b.21">Hakola 1990b</xref>].</p>
        </sec>
        <sec id="plosl.Surveillance">
          <title>Surveillance</title>
          <p>The interval of surveillance for bone lesions and neurologic and psychiatric manifestations must be determined individually.</p>
        </sec>
        <sec id="plosl.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="plosl.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="plosl.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="plosl.Other">
          <title>Other</title>
          <p>Calcium substitution alone has been shown to be ineffective in preventing the development of the osseous manifestations. The effect of bisphosphonates has not been studied.</p>
          <p>It has been speculated that nonsteroidal anti-inflammatory drugs (NSAIDs) could slow the progression of PLOSL; however, clinical trials have not been performed.</p>
          <p>A single individual with PLOSL improved temporarily when taking donepezil [D Hemelsoet, personal observation]. Clinical trials in a series of individuals with PLOSL have not been reported.</p>
        </sec>
      </sec>
      <sec id="plosl.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="plosl.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="plosl.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
              <p>Note: The sibs of an affected individual who are under age 40 years are at risk for PLOSL. Polycystic osseous lesions in radiographs of the hands and feet of an at-risk adult suggest the diagnosis.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of a <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> pathogenic variant is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an affected person are obligate heterozygotes for a <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> pathogenic variant. Because of the low carrier rate in the general population, the risk that an affected individual would have children with a carrier is very low except in genetic isolates.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> pathogenic variant.</p>
        </sec>
        <sec id="plosl.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="plosl.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being affected or carriers.</p>
            </list-item>
          </list>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with PLOSL is possible after molecular genetic testing has identified the specific pathogenic variants in the family. Such testing should be performed in the context of formal genetic counseling. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>Testing is appropriate to consider in symptomatic individuals in a family with an established diagnosis of PLOSL regardless of age.</p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="plosl.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TREM2</italic> or <italic toggle="yes">TYROBP</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for PLOSL are possible.</p>
        </sec>
      </sec>
      <sec id="plosl.Resources">
        <title>Resources</title>
      </sec>
      <sec id="plosl.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">TREM2</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">TREM2</italic> consists of five exons and codes for a 693-bp cDNA. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="plosl" object-id="plosl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> No normal variants have been reported.</p>
        <p><bold>Pathogenic variants.</bold> Several homozygous pathogenic variants have been identified. Most individuals with <italic toggle="yes">TREM2</italic> pathogenic variants have a previously unknown pathogenic variant [<xref ref-type="bibr" rid="plosl.REF.paloneva.2002.656">Paloneva et al 2002</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2003.669">Paloneva et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.soragna.2003.825">Soragna et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>]. Only pathogenic variants found in more than one family are presented here. For a more comprehensive list of published pathogenic variants, see <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al [2005]</xref>.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>c.233G&#x0003e;A,</bold> a pathogenic variant in the region encoding the extracellular domain of <italic toggle="yes">TREM2</italic>, results in premature termination of translation with no transmembrane and cytoplasmic domains after 77 amino acids. The pathogenic variant has been reported in two Swedish families with PLOSL [<xref ref-type="bibr" rid="plosl.REF.paloneva.2003.669">Paloneva et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>c.377T&#x0003e;G,</bold> a pathogenic variant in the region encoding the extracellular domain of <italic toggle="yes">TREM2</italic>, was found in one Canadian and one British individual with PLOSL, both originating from Sri Lanka [<xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>].</p>
          </list-item>
        </list>
        <table-wrap id="plosl.T.selected_trem2_pathogenic_varian" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">TREM2</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.40+3delAGG</td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nucleotide/189458827">NM_018965.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/9507203">NP_061838.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.113A&#x0003e;G</td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr38Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.197C&#x0003e;T</td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr66Met</td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.233G&#x0003e;A</td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp78Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.377T&#x0003e;G</td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val126Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.97C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_plosl.T.selected_trem2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln33Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="plosl.TF.2.1">
              <label>1. </label>
              <p>This variant has been reported to cause a PLOSL with typical bone pathology on radiologic examination but also a frontotemporal dementia-like syndrome without bone pathology on radiographs.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The protein encoded by <italic toggle="yes">TREM2</italic> has 230 amino acids and is an activating cell-surface receptor that forms a complex with the transmembrane adaptor protein TYROBP (DAP12). TREM2 is expressed by a variety of cells of myeloid origin [<xref ref-type="bibr" rid="plosl.REF.colonna.2003.445">Colonna 2003</xref>]. The natural ligand for TREM2 is unknown.</p>
        <p>The TREM2-TYROBP protein complex regulates the differentiation and function of osteoclasts, the bone-resorbing cells [<xref ref-type="bibr" rid="plosl.REF.cella.2003.645">Cella et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2003.669">Paloneva et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.humphrey.2005.50">Humphrey et al 2005</xref>]. In the CNS, TREM2 is expressed by microglial cells [<xref ref-type="bibr" rid="plosl.REF.colonna.2003.445">Colonna 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.kiialainen.2005.314">Kiialainen et al 2005</xref>]. The function of TREM2 in the CNS is unknown. TREM2 also activates monocyte-derived dendritic cells and is expressed by macrophages [<xref ref-type="bibr" rid="plosl.REF.bouchon.2001b.1111">Bouchon et al 2001b</xref>, <xref ref-type="bibr" rid="plosl.REF.colonna.2003.445">Colonna 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.thrash.2009.38">Thrash et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Depending on the type of pathogenic variant: either the defective TREM2 protein is truncated, not translated, or not transported to the cell surface; or the consequences of the pathogenic variant cannot be predicted.</p>
        <p>The differentiation of osteoclasts is impaired in TREM2-deficient individuals, and the cells show reduced bone resorption capability in vitro [<xref ref-type="bibr" rid="plosl.REF.cella.2003.645">Cella et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2003.669">Paloneva et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.humphrey.2005.50">Humphrey et al 2005</xref>].</p>
        <p>
          <bold><italic toggle="yes">TYROBP</italic> (previously known as <italic toggle="yes">DAP12</italic>)</bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">TYROBP</italic> consists of five exons and codes for a 342-bp cDNA. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="plosl" object-id="plosl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Several homozygous pathogenic variants have been identified. Three of them, c.-2897_276+1334del, p.Met1Thr, and p.Met48TrpfsTer6, have been found in more than one family with PLOSL [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kondo.2002.1105">Kondo et al 2002</xref>]. Other pathogenic variants reported in <italic toggle="yes">TYROBP</italic> have been found in single families only [<xref ref-type="bibr" rid="plosl.REF.baeta.2002.15">Baeta et al 2002</xref>, <xref ref-type="bibr" rid="plosl.REF.paloneva.2002.656">Paloneva et al 2002</xref>, <xref ref-type="bibr" rid="plosl.REF.kl_nemann.2005.1502">Kl&#x000fc;nemann et al 2005</xref>]. A single patient with a compound heterozygous pathogenic variant in <italic toggle="yes">TYROBP</italic> has been reported [<xref ref-type="bibr" rid="plosl.REF.kuroda.2007.88">Kuroda et al 2007</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>c.-2897_276+1334del.</bold> All Finnish individuals with PLOSL are homozygous for this deletion, which has also been found in Swedish and Norwegian families [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.tranebjaerg.2000.3196">Tranebjaerg et al 2000</xref>]. The 5.3-kb deletion encompasses the first four exons of <italic toggle="yes">TYROBP</italic>. Because the exon 1-4 deletion is an <italic toggle="yes">Alu-</italic> mediated recombination event, the breakpoint is not known precisely; here it is shown at the repetitive sequence at the 5&#x02019; end of the breakpoint. No mRNA encoding TYROBP (DAP12) is produced.</p>
          </list-item>
          <list-item>
            <p><bold>p.Met1Thr,</bold> a homozygous start methionine pathogenic variant, has been reported in two Japanese families with PLOSL [<xref ref-type="bibr" rid="plosl.REF.kondo.2002.1105">Kondo et al 2002</xref>]. This pathogenic variant results in conversion of the translation initiation methionine to threonine. No TYROBP (DAP12) polypeptide is produced.</p>
          </list-item>
          <list-item>
            <p><bold>p.Met48TrpfsTer6,</bold> another homozygous pathogenic variant, has been found in a number of Japanese individuals with PLOSL. This single-base deletion creates a frameshift in the open reading frame, resulting in a premature termination of the polypeptide chain after 52 amino acids, and changes a functionally critical aspartic acid residue in the transmembrane domain. The defective protein is not transported to the cell surface [<xref ref-type="bibr" rid="plosl.REF.paloneva.2000.357">Paloneva et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.kondo.2002.1105">Kondo et al 2002</xref>].</p>
          </list-item>
        </list>
        <table-wrap id="plosl.T.selected_tyrobp_pathogenic_varia" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">TYROBP</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.-2897_276+1334del&#x000a0;<sup>1</sup><break/>(5.3 kb deletion; deletion of ex 1-4)</td>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003332">NM_003332.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4507755">NP_003323.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2T&#x0003e;C</td>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.141delG</td>
                <td headers="hd_h_plosl.T.selected_tyrobp_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met48TrpfsTer6</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="plosl.TF.3.1">
              <label>1. </label>
              <p>Because the exon 1-4 deletion is an <italic toggle="yes">Alu-</italic> mediated recombination event, the breakpoint is not known precisely; here it is shown at the repetitive sequence at the 5&#x02019; end of the breakpoint.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The protein contains 113 amino acids and is a transmembrane adaptor protein that mediates the activation of a wide variety of cells of myeloid and lymphoid origin [<xref ref-type="bibr" rid="plosl.REF.lanier.1998b.703">Lanier et al 1998b</xref>, <xref ref-type="bibr" rid="plosl.REF.bakker.1999.9792">Bakker et al 1999</xref>, <xref ref-type="bibr" rid="plosl.REF.bouchon.2000.4991">Bouchon et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.bouchon.2001a.1103">Bouchon et al 2001a</xref>]. On the cell plasma membrane, TYROBP is expressed as a disulfide-bonded homodimer linked to the associated cell surface receptors. Numerous <italic toggle="yes">TYROBP</italic>-associated cell surface receptors in addition to TREM2 have been reported [<xref ref-type="bibr" rid="plosl.REF.lanier.1998a.693">Lanier et al 1998a</xref>, <xref ref-type="bibr" rid="plosl.REF.lanier.1998b.703">Lanier et al 1998b</xref>, <xref ref-type="bibr" rid="plosl.REF.bouchon.2000.4991">Bouchon et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.dietrich.2000.9">Dietrich et al 2000</xref>, <xref ref-type="bibr" rid="plosl.REF.diefenbach.2002.1142">Diefenbach et al 2002</xref>, <xref ref-type="bibr" rid="plosl.REF.gilfillan.2002.1150">Gilfillan et al 2002</xref>, <xref ref-type="bibr" rid="plosl.REF.lanier.2009.150">Lanier 2009</xref>]. The cytoplasmic domain of TYROBP contains an immunoreceptor tyrosine-based activation motif (ITAM) which on receptor engagement becomes phosphorylated and binds the cytoplasmic protein tyrosine kinases SYK and ZAP70 [<xref ref-type="bibr" rid="plosl.REF.lanier.1998b.703">Lanier et al 1998b</xref>]. This interaction results in intracellular calcium mobilization and subsequent cellular activation [<xref ref-type="bibr" rid="plosl.REF.mcvicar.1998.32934">McVicar et al 1998</xref>].</p>
        <p>The TYROBP-TREM2 protein complex regulates the differentiation and function of osteoclasts [<xref ref-type="bibr" rid="plosl.REF.paloneva.2003.669">Paloneva et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.humphrey.2004.224">Humphrey et al 2004</xref>]. In the CNS, TYROBP is expressed by microglial cells; the exact function of the protein in these cells is unknown [<xref ref-type="bibr" rid="plosl.REF.kiialainen.2005.314">Kiialainen et al 2005</xref>, <xref ref-type="bibr" rid="plosl.REF.takahashi.2005.647">Takahashi et al 2005</xref>, <xref ref-type="bibr" rid="plosl.REF.thrash.2009.38">Thrash et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Depending on the type of pathogenic variant: either the defective TYROBP protein is truncated, not translated, or not transported to the cell surface; or the consequences of the pathogenic variant cannot be predicted.</p>
        <p>The differentiation of osteoclasts in TYROBP-deficient individuals is impaired, and the osteoclasts show a reduced bone resorption capability in vitro [<xref ref-type="bibr" rid="plosl.REF.paloneva.2003.669">Paloneva et al 2003</xref>, <xref ref-type="bibr" rid="plosl.REF.humphrey.2004.224">Humphrey et al 2004</xref>].</p>
      </sec>
      <sec id="plosl.References">
        <title>References</title>
        <sec id="plosl.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="plosl.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="plosl.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 2-14-17.</mixed-citation>
            </ref>
            <ref id="plosl.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 2-14-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="plosl.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="plosl.Literature_Cited.reflist0">
            <ref id="plosl.REF.akai.1977.802">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateishi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morii</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>Membranous lipodystrophy: a clinicopathological study of six cases.</article-title>
                <source>J Bone Joint Surg Am</source>
                <volume>59</volume>
                <fpage>802</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">908704</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.amano.1987.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yagishita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iseki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>Nasu-Hakola's disease (membranous lipodystrophy).</article-title>
                <source>Acta Neuropathol</source>
                <volume>74</volume>
                <fpage>294</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3673522</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.aoki.2011.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Togo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchikado</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsuse</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujishiro</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iseki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirayasu</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Gray matter lesions in Nasu-Hakola disease: a report on three autopsy cases.</article-title>
                <source>Neuropathology.</source>
                <volume>31</volume>
                <fpage>135</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">20880319</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.araki.1991.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohba</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monzawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hachiya</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Membranous lipodystrophy: MR imaging appearance of the brain.</article-title>
                <source>Radiology</source>
                <volume>180</volume>
                <fpage>793</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1871295</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.ar_kan.2014">
              <mixed-citation publication-type="other">Ar&#x00131;kan M, Y&#x00131;ld&#x00131;r&#x00131;m A, Togral G, Ekmek&#x000e7;i AB. Extremity manifestations and surgical treatment for nasu hakola disease. Case Rep Orthop. 2014;2014:458728.</mixed-citation>
            </ref>
            <ref id="plosl.REF.baeta.2002.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baeta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guarda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Almeida</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parreira</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saraiva</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>S&#x000ed;ndroma Nasu-Hakola: um caso portugu&#x000ea;s.</article-title>
                <source>Sinapse</source>
                <volume>2</volume>
                <fpage>15</fpage>
                <lpage>8</lpage>
              </element-citation>
            </ref>
            <ref id="plosl.REF.bakker.1999.9792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>96</volume>
                <fpage>9792</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10449773</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.bird.1983.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koerker</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leaird</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlcek</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorning</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Lipomembranous polycystic osteodysplasia (brain, bone, and fat disease): a genetic cause of presenile dementia.</article-title>
                <source>Neurology</source>
                <volume>33</volume>
                <fpage>81</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">6681564</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.bock.2013.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bock</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botturi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaviani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamperti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maccagnano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmaggi</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): a new report of an Italian woman and review of the literature.</article-title>
                <source>J Neurol Sci.</source>
                <year>2013</year>
                <volume>326</volume>
                <fpage>115</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23399524</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.bouchon.2000.4991">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouchon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.</article-title>
                <source>J Immunol</source>
                <volume>164</volume>
                <fpage>4991</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10799849</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.bouchon.2001a.1103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouchon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Facchetti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weigand</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>TREM-1 amplifies inflammation and is a crucial mediator of septic shock.</article-title>
                <source>Nature</source>
                <volume>410</volume>
                <fpage>1103</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11323674</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.bouchon.2001b.1111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouchon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hern&#x000e1;ndez-Munain</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.</article-title>
                <source>J Exp Med</source>
                <volume>194</volume>
                <fpage>1111</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11602640</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.cella.2003.645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buonsanti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strader</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmaggi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Impaired differentiation of osteoclasts in TREM-2-deficient individuals.</article-title>
                <source>J Exp Med</source>
                <volume>198</volume>
                <fpage>645</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12913093</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.chouery.2008.e194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chouery</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delague</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergougnoux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koussa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutations in TREM2 lead to pure early-onset dementia without bone cysts.</article-title>
                <source>Hum Mutat</source>
                <volume>29</volume>
                <fpage>E194</fpage>
                <lpage>E204</lpage>
                <pub-id pub-id-type="pmid">18546367</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.colonna.2003.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>TREMs in the immune system and beyond.</article-title>
                <source>Nat Rev Immunol</source>
                <volume>3</volume>
                <fpage>445</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12776204</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.diefenbach.2002.1142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diefenbach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomasello</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsia</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vivier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raulet</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.</article-title>
                <source>Nat Immunol</source>
                <volume>3</volume>
                <fpage>1142</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12426565</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.dietrich.2000.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dietrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seiffert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;hring</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells.</article-title>
                <source>J Immunol</source>
                <volume>164</volume>
                <fpage>9</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">10604985</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.gilfillan.2002.1150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gilfillan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colonna</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.</article-title>
                <source>Nat Immunol</source>
                <volume>3</volume>
                <fpage>1150</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12426564</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.guerreiro.2013a.2890.e1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilgic</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guven</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e1;s</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanagasi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurvit</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emre</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.</article-title>
                <source>Neurobiol Aging.</source>
                <year>2013a</year>
                <volume>34</volume>
                <fpage>2890.e1</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23870839</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.guerreiro.2013b.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wojtas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrasquillo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogaeva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majounie</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruchaga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauwe</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younkin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hazrati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collinge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pocock</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lashley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouyel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St George-Hyslop</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <collab>Alzheimer Genetic Analysis Group</collab>
                </person-group>
                <year>2013b</year>
                <article-title>TREM2 variants in Alzheimer's disease.</article-title>
                <source>N Engl J Med.</source>
                <volume>368</volume>
                <fpage>117</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">23150934</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.guerreiro.2013c.78">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e1;s</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohrer</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurunlian</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dursun</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilgic</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanagasi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurvit</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013c</year>
                <article-title>Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.</article-title>
                <source>JAMA Neurol.</source>
                <volume>70</volume>
                <fpage>78</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">23318515</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.hakola.1972.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>1972</year>
                <article-title>Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia.</article-title>
                <source>Acta Psychiatr Scand Suppl</source>
                <volume>232</volume>
                <fpage>1</fpage>
                <lpage>173</lpage>
                <pub-id pub-id-type="pmid">4509294</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.hakola.a">
              <mixed-citation publication-type="book">Hakola HP. Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (membranous lipodystrophy): a neuropsychiatric follow-up study. In: Henriksson M, Huttunen M, Kuoppasalmi K, Lindfors O, Lonnqvist J, eds. <italic toggle="yes">Monographs of Psychiatria Fennica.</italic> Monograph 17. Helsinki, Finland: Foundation for Psychiatric Research; 1990a:1-114</mixed-citation>
            </ref>
            <ref id="plosl.REF.hakola.1990b.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>1990b</year>
                <article-title>Psychosocial reactions in the spouses of patients suffering polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.</article-title>
                <source>J Clin Psychiatry</source>
                <volume>51</volume>
                <fpage>21</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">2295586</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.hakola.1998.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Benton's Visual Retention Test in patients with polycystic lipomembranous dysplasia with sclerosing leukoencephalopathy.</article-title>
                <source>Dement Geriatr Cogn Disord</source>
                <volume>9</volume>
                <fpage>39</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">9469264</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.hakola.1983.515">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partanen</surname>
                    <given-names>VS</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Neurophysiological findings in the hereditary presenile dementia characterised by polycystic lipomembranous osteodysplasia and sclerosing leukoencephalopathy.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>46</volume>
                <fpage>515</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">6410004</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.hakola.1993.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puranen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Neuropsychiatric and brain CT findings in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>88</volume>
                <fpage>370</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8296538</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.humphrey.2005.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Humphrey</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Role of ITAM-containing adapter proteins and their receptors in the immune system and bone.</article-title>
                <source>Immunol Rev</source>
                <volume>208</volume>
                <fpage>50</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">16313340</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.humphrey.2004.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Humphrey</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogasawara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spusta</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daws</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.</article-title>
                <source>J Bone Miner Res</source>
                <volume>19</volume>
                <fpage>224</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">14969392</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.ilonen.2012.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilonen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhanen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiihonen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Rorschach assessment of personality functioning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.</article-title>
                <source>Acta Neuropsychiatr.</source>
                <volume>24</volume>
                <fpage>236</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">25286817</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.ishigooka.1993.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishigooka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumiya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kodama</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakada</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Membranous lipodystrophy (Nasu's disease): a rare cause of neuropathic urinary incontinence.</article-title>
                <source>Urol Int</source>
                <volume>50</volume>
                <fpage>179</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">8465487</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.jin.2014.5838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benitez</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karch</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skorupa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harari</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertelsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruchaga</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Coding variants in TREM2 increase risk for Alzheimer's disease.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>23</volume>
                <fpage>5838</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">24899047</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.jonsson.2013.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsdottir</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsson</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snaedal</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huttenlocher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levey</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lah</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rujescu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giegling</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassen</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engedal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulstein</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Djurovic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibrahim-Verbaas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikram</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorsteinsdottir</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Variant of TREM2 associated with the risk of Alzheimer's disease.</article-title>
                <source>N Engl J Med.</source>
                <volume>368</volume>
                <fpage>107</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">23150908</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kalimo.1994.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sourander</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Vascular changes and blood-brain barrier damage in the pathogenesis of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (membranous lipodystrophy).</article-title>
                <source>Acta Neurol Scand</source>
                <volume>89</volume>
                <fpage>353</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">8085433</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kiialainen.2005.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kiialainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovanes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopra</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.</article-title>
                <source>Neurobiol Dis</source>
                <volume>18</volume>
                <fpage>314</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15686960</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kitajima.1989.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kitajima</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuriyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Usuki</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suganuma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagamatsu</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Nasu-Hakola disease (membranous lipodystrophy). Clinical, histopathological and biochemical studies of three cases.</article-title>
                <source>J Neurol Sci</source>
                <volume>91</volume>
                <fpage>35</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">2746291</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kl_nemann.2005.1502">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kl&#x000fc;nemann</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridha</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magy</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wherrett</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hemelsoet</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keen</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Bleecker</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossor</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marienhagen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>1502</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15883308</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kobayashi.2000.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muramori</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiramatsu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koshino</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Hypothalamic haemorrhage and thalamus degeneration in a case of Nasu-Hakola disease with hallucinatory symptoms and central hypothermia.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <volume>26</volume>
                <fpage>98</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">10787346</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kondo.2002.1105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamura</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1105</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12370476</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.kuroda.2007.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuroda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satoh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anezaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizoguchi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease.</article-title>
                <source>J Neurol Sci</source>
                <volume>252</volume>
                <fpage>88</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">17125796</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.lanier.2009.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>DAP10- and DAP12-associated receptors in innate immunity.</article-title>
                <source>Immunol Rev.</source>
                <volume>227</volume>
                <fpage>150</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">19120482</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.lanier.1998a.693">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corliss</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Association of DAP12 with activating CD94/NKG2C NK cell receptors.</article-title>
                <source>Immunity</source>
                <volume>8</volume>
                <fpage>693</fpage>
                <lpage>701</lpage>
                <pub-id pub-id-type="pmid">9655483</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.lanier.1998b.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corliss</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leong</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.</article-title>
                <source>Nature</source>
                <volume>391</volume>
                <fpage>703</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9490415</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.le_ber.2014.2419.e23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Septenville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caroppo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lattante</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couarch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabashi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouya-Ahmed</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Homozygous TREM2 mutation in a family with atypical frontotemporal dementia.</article-title>
                <source>Neurobiol Aging.</source>
                <volume>35</volume>
                <fpage>2419.e23</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24910390</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.m_kel_.1982.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000e4;kel&#x000e4;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rv&#x000ed;</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Virtama</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Radiologic bone changes of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.</article-title>
                <source>Skeletal Radiol</source>
                <volume>8</volume>
                <fpage>51</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">7079784</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.matsuo.1982.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suetsugu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuneyoshi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Membranous lipodystrophy. A case report.</article-title>
                <source>Arch Psychiatr Nervenkr</source>
                <volume>231</volume>
                <fpage>123</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">7065860</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.mcvicar.1998.32934">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McVicar</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gosselin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willette-Brown</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikhael</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geahlen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linnemeyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seaman</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortaldo</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mason</surname>
                    <given-names>LH</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase.</article-title>
                <source>J Biol Chem</source>
                <volume>273</volume>
                <fpage>32934</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">9830044</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.minagawa.1985.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Minagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maeshiro</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shioda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>Membranous lipodystrophy (Nasu disease): clinical and neuropathological study of a case.</article-title>
                <source>Clin Neuropathol</source>
                <volume>4</volume>
                <fpage>38</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">2983919</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.miyazu.1991.414">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyazu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukutani</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitoh</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Membranous lipodystrophy (Nasu-Hakola disease) with thalamic degeneration: report of an autopsied case.</article-title>
                <source>Acta Neuropathol</source>
                <volume>82</volume>
                <fpage>414</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">1722609</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.motohashi.1995.549">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Motohashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinohara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shioe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuzawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariya</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>A case of membranous lipodystrophy (Nasu-Hakola disease) with unique MRI findings.</article-title>
                <source>Neuroradiology</source>
                <volume>37</volume>
                <fpage>549</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">8570051</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.nasu.1973.539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nasu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsukahara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terayama</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1973</year>
                <article-title>A lipid metabolic disease-"membranous lipodystrophy"-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues.</article-title>
                <source>Acta Pathol Jpn</source>
                <volume>23</volume>
                <fpage>539</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">4800725</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.nwawka.2014.1449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nwawka</surname>
                    <given-names>OK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bansal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mintz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Membranous lipodystrophy: skeletal findings on CT and MRI.</article-title>
                <source>Skeletal Radiol</source>
                <volume>43</volume>
                <fpage>1449</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">24777445</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.paloneva.2001.1552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Autti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raininko</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partanen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salonen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puranen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haltia</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>1552</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11402114</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.paloneva.2000.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kestil&#x000e4;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salminen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;hling</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruotsalainen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pekkarinen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanier</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timonen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.</article-title>
                <source>Nat Genet</source>
                <volume>25</volume>
                <fpage>357</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">10888890</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.paloneva.2003.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiialainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohling</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prudlo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haltia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konttinen</surname>
                    <given-names>YT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.</article-title>
                <source>J Exp Med</source>
                <volume>198</volume>
                <fpage>669</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">12925681</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.paloneva.2002.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manninen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovanes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adolfsson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmaggi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konttinen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>656</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">12080485</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.pekkarinen.1998.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pekkarinen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovatta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kestil&#x000e4;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenkkeri</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adolfsson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmgren</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nylander</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwilliger</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>362</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">9463329</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.solje.2014.1780.e13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Solje</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartikainen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanninen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiihonen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tienari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remes</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>The C9ORF72 expansion does not affect the phenotype in Nasu-Hkola disease with the DAP12 mutation.</article-title>
                <source>Neurobiology of aging</source>
                <volume>35</volume>
                <fpage>1780.e13</fpage>
                <lpage>1780.e17</lpage>
                <pub-id pub-id-type="pmid">24612676</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.soragna.2003.825">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Soragna</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ratti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sestini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tupler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montalbetti</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>74</volume>
                <fpage>825</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12754369</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.takahashi.2005.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochford</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.</article-title>
                <source>J Exp Med</source>
                <volume>201</volume>
                <fpage>647</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">15728241</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.takeshita.2005.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takeshita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatsumi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatanaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furui</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Regional cerebral blood flow in a patient with Nasu-Hakola disease.</article-title>
                <source>Ann Nucl Med</source>
                <volume>19</volume>
                <fpage>309</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16097640</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.tanaka.1980.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1980</year>
                <article-title>Leukoencephalopathic alteration in membranous lipodystrophy.</article-title>
                <source>Acta Neuropathol</source>
                <volume>50</volume>
                <fpage>193</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7415812</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.thrash.2009.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thrash</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torbett</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carson</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease.</article-title>
                <source>Neurochem Res.</source>
                <volume>34</volume>
                <fpage>38</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">18404378</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.tranebjaerg.2000.3196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrader</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Polycystic lipomembranous osteodysplasia</article-title>
                <comment>[Article in Norwegian]</comment>
                <source>Tidsskr Nor Laegeforen</source>
                <volume>120</volume>
                <fpage>3196</fpage>
                <pub-id pub-id-type="pmid">11109371</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.vanhanen.2013.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanhanen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilonen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiihonen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.</article-title>
                <source>Dement Geriatr Cogn Dis Extra.</source>
                <year>2013</year>
                <volume>3</volume>
                <fpage>10</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23569454</pub-id>
              </element-citation>
            </ref>
            <ref id="plosl.REF.verloes.1997.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maquet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadzot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vivario</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiry</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franck</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia.</article-title>
                <source>J Med Genet</source>
                <volume>34</volume>
                <fpage>753</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9321763</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="plosl.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="plosl.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>12 March 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 August 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 April 2009 (jp) Revision: sequence analysis available on a clinical basis for <italic toggle="yes">TYROBP</italic> and <italic toggle="yes">TREM2</italic></p>
            </list-item>
            <list-item>
              <p>1 May 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 March 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 January 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>31 October 2001 (jp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="plosl.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>A radiograph of the hand of a person with PLOSL demonstrates multiple cyst-like lesions and loss of bone trabeculae.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="plosl-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="plosl.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>A radiograph shows a well-demarcated cyst-like lesion (arrow) in the talus of a 28-year old with PLOSL [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>; reprinted with permission from <italic toggle="yes">Neurology</italic>]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="plosl-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="plosl.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>T<sub>2</sub>-weighted MR image of a 33-year-old shows very low signal intensity in the putamina. Signal intensities are higher in the central white matter (including internal capsules) than in the deep gray matter structures. The central white matter partially has a higher signal intensity than the cortex. The white matter changes are diffuse and most of the arcuate fibers are not affected. The heads of the caudate nuclei are very small. The corpus callosum is thin and the ventricles and sulci are moderately enlarged [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>; reprinted with permission from <italic toggle="yes">Neurology</italic>].</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="plosl-Image003" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="plosl.F4" orientation="portrait">
          <label>Figure 4. </label>
          <caption>
            <p>T<sub>2</sub>-weighted MR image of a 32-year-old displays severely enlarged cerebral sulci and lateral ventricles. Note high periventricular signal intensity spreading toward periphery. The arcuate fibers are partly spared [<xref ref-type="bibr" rid="plosl.REF.paloneva.2001.1552">Paloneva et al 2001</xref>; reprinted with permission from <italic toggle="yes">Neurology</italic>].</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="plosl-Image004" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="plosl.F5" orientation="portrait">
          <label>Figure 5. </label>
          <caption>
            <p>Brain MRI. High intensity lesions in the bilateral periventricular white matter on an axial FLAIR image (TR: 8000 ms, TE: 120 ms) [<xref ref-type="bibr" rid="plosl.REF.kuroda.2007.88">Kuroda et al 2007</xref>; reprinted with permission from <italic toggle="yes">Elsevier</italic>]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="plosl-Image005" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="plosl.F6" orientation="portrait">
          <label>Figure 6. </label>
          <caption>
            <p>Contents of a cyst-like bone lesion. Microscopically, the lesions contain (C) convoluted lipid membrane structures filled with amorphous lipid substance and (F) fat. (B) Bone trabeculae are partially preserved. Scale bar corresponds to 250 &#x003bc;m [van Gieson].</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="plosl-Image006" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
